Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Henning

Showing results (161-170 of 176) with videos related to

Pageof 18
Sort By:
Plos One|June 13, 2017
Potential therapeutic impact of CD13 expression in non-small cell lung cancerLars Henning Schmidt, Caroline Brand, Janine Stucke-Ring, et al.
Plos One|August 10, 2017
Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancerLars Henning Schmidt, Caroline Brand, Janine Stucke-Ring, et al.
European Journal of Haematology|March 29, 2017
Progressive histoplasmosis with hemophagocytic lymphohistiocytosis and epithelioid cell granulomatosis: A case report and review of the literatureArik Bernard Schulze, Britta Heptner, Torsten Kessler, et al.
Plos One|October 28, 2017
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancerLars Henning Schmidt, Birthe Heitkötter, Arik B Schulze, et al.
Oncotarget|June 3, 2017
The collagen receptor uPARAP/Endo180 as a novel target for antibody-drug conjugate mediated treatment of mesenchymal and leukemic cancersChristoffer Fagernæs Nielsen, Sander Maarten van Putten, Ida Katrine Lund, et al.
Translational Oncology|August 21, 2018
Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue SarcomaTorsten Kessler, Ariane Baumeier, Caroline Brand, et al.
Oncotarget|October 15, 2016
Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarctionJanine Stucke-Ring, Julian Ronnacker, Caroline Brand, et al.
Oncogene|December 8, 2020
NOP10 predicts lung cancer prognosis and its associated small nucleolar RNAs drive proliferation and migrationChunhong Cui, Yi Liu, Dennis Gerloff, et al.
Scientific Reports|May 13, 2016
C4.4A gene ablation is compatible with normal epidermal development and causes modest overt phenotypesMette Camilla Kriegbaum, Benedikte Jacobsen, Annette Füchtbauer, et al.
Prenatal Diagnosis|March 23, 2025
Whole Genome Sequencing in Prenatal Diagnostics: The Danish Approach to Guideline Formation and Implementation Within Public HealthcareIda Vogel, Lotte Andreasen, Marie Balslev-Harder, et al.
Pageof 18

Showing results (161-170 of 176) with videos related to

Sort By:
Pageof 18
Plos One|June 13, 2017
Potential therapeutic impact of CD13 expression in non-small cell lung cancerLars Henning Schmidt, Caroline Brand, Janine Stucke-Ring, et al.
Plos One|August 10, 2017
Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancerLars Henning Schmidt, Caroline Brand, Janine Stucke-Ring, et al.
European Journal of Haematology|March 29, 2017
Progressive histoplasmosis with hemophagocytic lymphohistiocytosis and epithelioid cell granulomatosis: A case report and review of the literatureArik Bernard Schulze, Britta Heptner, Torsten Kessler, et al.
Plos One|October 28, 2017
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancerLars Henning Schmidt, Birthe Heitkötter, Arik B Schulze, et al.
Oncotarget|June 3, 2017
The collagen receptor uPARAP/Endo180 as a novel target for antibody-drug conjugate mediated treatment of mesenchymal and leukemic cancersChristoffer Fagernæs Nielsen, Sander Maarten van Putten, Ida Katrine Lund, et al.
Translational Oncology|August 21, 2018
Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue SarcomaTorsten Kessler, Ariane Baumeier, Caroline Brand, et al.
Oncotarget|October 15, 2016
Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarctionJanine Stucke-Ring, Julian Ronnacker, Caroline Brand, et al.
Oncogene|December 8, 2020
NOP10 predicts lung cancer prognosis and its associated small nucleolar RNAs drive proliferation and migrationChunhong Cui, Yi Liu, Dennis Gerloff, et al.
Scientific Reports|May 13, 2016
C4.4A gene ablation is compatible with normal epidermal development and causes modest overt phenotypesMette Camilla Kriegbaum, Benedikte Jacobsen, Annette Füchtbauer, et al.
Prenatal Diagnosis|March 23, 2025
Whole Genome Sequencing in Prenatal Diagnostics: The Danish Approach to Guideline Formation and Implementation Within Public HealthcareIda Vogel, Lotte Andreasen, Marie Balslev-Harder, et al.
Pageof 18